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Comparative study about central blood pressure and arterial elasticity in
hypertensive patients combined with diabetic
Yingxin Zhao, Fanghong Lu, Zhendong Liu, Zhihui Yan, Shujian Wang, Yingying Zhao
Cardio-Cerebrovascular Control and Research Center, Shandong Academy of Medical
Sciences
Objectives: To explore the alter of central aortic pressure and parameters, crPWV
after joint buck hypoglycemic.
Methods: 280 patients with essential hypertension and type 2 diabetes aged from 60
to 79 years old were recruited, and 240 patients were randomized into four groups
after 2 months of screening, namely, strengthen antihypertensive and strengthen hy-
poglycemic group, strengthen antihypertensive and conventional hypoglycemic group,
standard buck and strengthen hypoglycemic group, standard buck and conventional
hypoglycemic group. Strengthen hypoglycemic group was therapied by gliclazide.
Insulin and other could be added when necessary. Conventional hypoglycemic group
only taked antidiabetic drugs except gliclazide. All the subjects were collected blood
and urine samples at the baseline and the end of the study. Basic clinical datas of all
patients such as age, weight, height, BP, HR, ECG and others were collected. Central
aortic pressures and carotid-radial pulse wave velocity (crPWV) were carried out
noninvasively by using SphygmoCor device.
Results: The rates of decline of CSP (16.968.19mmHg), CDP (2.031.67mmHg),
CPP (11.682.05mmHg), CMSP (10.757.74mmHg), CMDP (7.0412.66mmHg),
CESP (10.3811.40mmHg),P1 Height (11.2710.86) on group I was greater than
the other 3 groups after treatmen (P<0.05); The rate of decline ofCSP (9.378.05mmHg/
5.589.01mmHg), CPP (7.172.51mmHg/5.012.36mmHg), CMSP (5.798.33
mmHg/5.148.96mmHg), CESP (4.8611.97mmHg/5.0812.75mmHg), P1 Height
(6.748.43/6.983.39) and AI (10.2918.13%/6.4719.31%) on group II and III
were greater than group IV after treatmen (P<0.05) The rate of decline of CSP, CMSP
on group II were greater than grpup III, P<0.05. The rate of decline of crPWV
(4.664.93m/s) on group I was greater than the other 3 groups after treatment (P<0.05).
Conclusions: The central aortic pressure and its reﬂected waves, the ﬂexible functions
of vascular were be improved by combined therapy.
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Changes in pregnancy outcomes of hypertensive disorder complicating
pregnancy in Shanghai between 2001 and 2010
Wu Juanli, Guanghua Wang, Liling Zou, Liang Zheng, Jue Li
The department of clinical epidemiology, Tongji University School of Medicine,
Shanghai, China
Objectives: To estimate the prevalence and relative risk factors of hypertensive
disorder complicating pregnancy (HDCP), to compare changes in pregnancy out-
comes of HDCP between 2001 and 2010.
Methods:We carried out a retrospective cohort study of pregnancy women (n¼3008)
giving birth in 2001 and 2010 in Shanghai tenth people’s hospital. Chi-square test was
conducted to compare the incident status of HDCP and changes in pregnancy
outcomes. Multiples logistic regression was used to explore potential risk factors of
HDCP. All statistical analyses were performed by SAS 9.1.3.
Results: The prevalence of HDCP in 2001 (6.52%) was obviously higher than 2010
(2.93%) (c2¼21.68, P<0.001). There were 124 women with HDCP in total, with 65
occurred in 2001 and 59 in 2010. Among women with HDCP, the incidence of
adverse maternal outcomes in 2010 was declined compared with 2001, such as
postpartum hemorrhage, stillbirth, and fetal distress, but unfortunately, no signiﬁcant
statistical difference was found. The incidence of fetal distress was decreased from
7.69%-3.39%, and that of premature rupture of membranes was from 4.62%-1.69%.
The incidence of adverse neonatal outcomes was also declined except for premature
baby, whose incidence was increased from 10.77%-16.95%. Adjusted maternal age,
history of diabetes, anemia, history of cardiovascular disease, multiple pregnancies,
and family history of hypertension, the last two variables entered in the ﬁnal logistic
regression model. Multiple pregnancies [OR 4.5, 95% CI 1.5-13.4] and family history
of hypertension [OR 5.7, 95% CI 1.6-20.1] are correlated with HDCP.
Conclusions: The prevalence of HDCP in 2010 is much lower than ten years ago
which may indicate that HDCP was given more attention and better prevention
than 2001. Multiple pregnancies and higher family history of hypertension were
risk factors of HDCP. The incidence of adverse pregnancy outcomes was declined
in some extent.
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Goal of blood pressure in patients with chronic kidney disease: from the Survey
of Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease
Patients with Hypertension in China (PATRIOTIC)
Zheng Ying, Guangyan Cai, Xiangmei Chen
Department of Nephrology, Chinese PLA General HospitalC170 JACC Vol 64/16/Suppl C j October 16–1Objectives: Hypertension is closely associated with the decreased renal function,
cardiovascular morbidity and mortality. It is well known that patients with chronic
kidney disease (CKD) need aggressive antihypertensive treatment. However, the
current guidelines rely more on experts’ opinions than clinical evidences. In addition,
as there is an “upper limit” of goal blood pressure (BP) in current guidelines, it will be
useful to set a “lower limit” of BP for clinical practice. Thus, we referred to the normal
range of laboratory values so that we could set goal BP ranges for different age
groups’ CKD patients.
Methods: A Survey of Prevalence, Awareness, and Treatment Rates in Chronic
Kidney Disease Patients with Hypertension in China (PATRIOTIC) was performed in
61 tertiary hospitals from 31 provinces, municipalities, and autonomous regions in
China (except Hong Kong, Macao, and Taiwan). Trained physicians measured BP and
collected clinical data following a standard protocol. The decreased renal function was
deﬁned as glomerular ﬁltration rate (GFR) <60mL/min/1.73 m2. Cardiovascular
disease was deﬁned as coronary artery disease, left ventricular hypertrophy, conges-
tive heart failure, or arteriosclerosis. Cerebrovascular disease was deﬁned as stroke.
Systolic BP was classiﬁed as 170 mmHg, 160-169 mmHg, 150-159 mmHg,
140-149 mmHg, 130-139 mmHg, 120-129 mmHg, 110-119 mmHg, and <110
mmHg. Diastolic BP was classiﬁed as 120 mmHg, 110-119 mmHg, 100-109
mmHg, 90-99 mmHg, 80-89 mmHg, 70-79 mmHg, 60-69 mmHg, and <60 mmHg.
Results: The analysis included 8927 non-dialysis CKD patients. 6513 aged < 60
years, and 2414 60 years. In < 60 years group, 3954 had no decreased renal
function, 5989 had no cardiovascular disease, and 6372 had no cerebrovascular dis-
ease; the most common BP ranges without decreased renal function, cardiovascular,
and cerebrovascular disease were 120-129/70-79mmHg (SBP 28.2%, DBP 36.0%),
120-129/70-79mmHg (SBP 23.8%, DBP 30.3%), and 120-129/80-89mmHg (SBP
22.8%, DBP 29.9%), respectively. In  60 years group, 770 had no decreased renal
function, 1563 had no cardiovascular disease, and 2087 had no cerebrovascular dis-
ease; the most common BP ranges without decreased renal function, cardiovascular,
and cerebrovascular disease were 120-129/80-89mmHg (SBP 23.2%, DBP 37.4%),
130-139/80-89mmHg (SBP 19.6%, DBP 34.1%), and 130-139/ 80-89mmHg (SBP
18.4%, DBP 32.9%), respectively.
Conclusions: To reduce the occurrence of decreased renal function, cardiovascular,
and cerebrovascular disease, it would be better to maintain BP 120-129/70-89mmHg
in CKD patients at <60 years, and to maintain BP 120-139/80-89mmHg in CKD
patients at 60 years.
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Molecular mechanism and characterization of maternally inherited essential
hypertension
Li Zongbin, Li Jiayue, Liu Yuqi, Li Yang, Zhao Yusheng, Lu Caiyi, Chen Yundai
Department of Cardiology, Chinese People’s Liberation Army General Hospital
Objectives: We aimed to observe the relationship between the mitochondrial tRNA
mutation and the essential hypertension by examining the mutation of four tRNA
(tRNALys, tRNAIle, tRNAGln and tRNAMet). We also wanted to explore the inherited
signs and clinical characters of maternaly inherited essential hypertension.
Methods: We collected the data of general information, blood routine test, blood
biochemical examination and color Doppler echocardiography examination of the
subjects. We extracted DNA from subject’s white blood cell, and ampliﬁcated the
target fragment using the special primers. We then puriﬁed the PCR products, and then
we directly sequenced them. At last, we analysised the sequencing results and blasted
it on net. We also made a comparative analysis of the collected data of the essential
hypertension subjects who carried tRNA mutation and those who did not carry
mutation using the methods of 1:1 case-control study.
Results: (1) From the mutation analysis of mitochondrial DNA of 2,000 essential
hypertensive subjects, we totally found 26 mutation sites in 57 subjects, and 22
mutation sites were new. The most frequently occurrence of the mutation site was
A4386G in tRNAGln gene, next to this was G4394A in the same tRNA gene. (2) The
onset ages of the individuals carrying the mutation were earlier than those who did not
bear them, which was not associated with the change of body mass index. (3) tRNA
mutations signiﬁcantly affected serum lipids, blood electrolyte, blood creatinine,
blood urea nitrogen and heart structure and function, and different tRNA mutations
produced different effections. (4) Most essential hypertensive patients had maternally
inherited history, which fulﬁlled the feature of mitochondrial hereditary.
Conclusions: (1) Mitochondrial tRNA mutations might result in the change of their
structure and function, and then damaged the blood metabolism, the balance of the
blood electrolyte, the steady-state of the blood cells and the heart structure and
function, which were involved in the progress of the essential hypertension. (2) Part of
the essential hypertension patients clinically presented the characters of maternal
inheritance, which might be associated with the tRNA mutation.
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Elevated Uric Acid biosynthesis is Associated with Injured Vascular Function
in Patients with Pregnancy-Induced Hypertension
Zhao Juan, Zhang Xingtong, Wang Miao, Zhao Juan
First Afﬁliated Hospital of Harbin Medical University
Objectives: Patients who develop pregnancy-induced hypertension (PIH) exhibit a
striking increase in uric acid biosynthesis than healthy subjects, which may deteriorate
injured vascular function. This study was to evaluate the association between
hyperuricemia and vascular dysfunction in patients with PIH.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
